41 – 50 of 59
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
ID2 expression in neuroblastoma does not correlate to MYCN levels and lacks prognostic value
(
- Contribution to journal › Article
- 2002
-
Mark
The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node
(
- Contribution to journal › Article
-
Mark
Co-existence of SYT-SSX1 and SYT-SSX2 fusions in synovial sarcomas
(
- Contribution to journal › Article
-
Mark
Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers
(
- Contribution to journal › Article
-
Mark
SHP-2 is involved in heterodimer specific loss of phosphorylation of Tyr771 in the PDGF-beta receptor
(
- Contribution to journal › Article
- 2001
-
Mark
The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25
(
- Contribution to journal › Article
- 1999
-
Mark
Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor/c-kit mediated activation of the Ras/MAP kinase pathway and c-fos induction
(
- Contribution to journal › Article
-
Mark
Increased mitogenicity of an alphabeta heterodimeric PDGF receptor complex correlates with lack of RasGAP binding
(
- Contribution to journal › Article
-
Mark
Characterization of the chronic myelomonocytic leukemia associated TEL-PDGF beta R fusion protein
(
- Contribution to journal › Article
-
Mark
SHP-2 binds to Tyr763 and Tyr1009 in the PDGF beta-receptor and mediates PDGF-induced activation of the Ras/MAP kinase pathway and chemotaxis
(
- Contribution to journal › Article